James Horgan

Assistant Managing Counsel, Merck Sharp & Dohme

James Horgan is Assistant Managing Counsel at Merck Sharp & Dohme Corp. where he heads the European Patent Department. He has a degree in chemistry and has practiced extensively in the pharmaceutical, vaccine and biotechnological fields for 20 years. He has supported research sites for Merck in England and Italy. He has wide experience of prosecuting applications before the EPO where he regularly appears in ex parte and inter partes Oral Proceedings. He has filed and prosecuted a large number of SPCs. He has been involved in major multi-jurisdictional litigation for Merck in cases relating to Vioxx, Fosamax, Cosopt and Propecia, as well as in the parallel import case Merck v Sigma recently decided by the CJEU. He has completed an LLM in Intellectual Property Litigation through Nottingham Trent University. He is also involved in IP policy issues via the IPFederation, EFPIA and Business Europe.